Biomedical Engineering Reference
In-Depth Information
Rio, J. and Montalban, X. 2005. Interferon-β
1b
in the treatment of multiple sclerosis.
Expert Opinion on Pharma-
cotherapy
6
(16), 2877-2886.
Schroder, K., Hertzog, P.J., Ravasi, T., and Hume, D.A. 2004. Interferon gamma: an overview of signals, mecha-
nisms and function.
Journal of Leukocyte Biology
75
(2), 163-189.
Simko, R. and Nagy, K. 1996. Interferon-alpha in childhood hematological malignancies.
Postgraduate Medical
Journal
72
(854), 709-713.
Sleijfer, S., Bannink, M., van Cool, A.R., Kruit, W.H.J., and Stoter, G. 2005. Side effects of interferon-α therapy.
Pharmacy World and Science
27
(6), 423-431.
Soos, J. and Johnson, H. 1999. Interferon-τ. Prospects for clinical use in autoimmune disorders.
BioDrugs
11
(2),
125-135.
Todd, P. and Goa, K. 1992. Interferon gamma-1b.
Drugs
43
(1), 111-122.
Tossing, G. 2001. New developments in interferon therapy.
European Journal of Medical Research
6
(2), 47-65.
Veronese, F.M. and Pasut, G. 2005. PEGylation, successful approach to drug delivery.
Drug Discovery Today
10
, 1451-1458.
Wang, Y.-S., Youngster, S., Grace, M., Bausch, J., Bordens, R., and Wyss, D.F. 2002. Structural and biologi-
cal characterization of pegylated recombinant interferon alpha-2b and its therapeutic implications.
Advanced
Drug Delivery Reviews
54
(4), 547-570
Woo, M. and Burnakis, T. 1997. Interferon-alpha in the treatment of chronic viral hepatitis-B and viral hepatitis
C.
Annals of Pharmacotherapy
31
(3), 330-337.
Younes, H. and Amsden, B. 2002. Interferon-gamma therapy: evaluation of routes of administration and delivery
systems.
Journal of Pharmaceutical Sciences
91
(1), 2-17.
Young, H. and Hardy, K. 1995. Role of interferon-γ in immune cell regulation.
Journal of Leukocyte Biology
58
,
373-379.
Zavyalov, V. and Zavyalova, G. 1997. Interferons alpha/beta and their receptors - place in the hierarchy of
cytokines.
APMIS
105
(3), 161-186
Search WWH ::
Custom Search